Overview and Scope
Pediatric interventional cardiology refers to procedures that use cardiac catheterization in children to diagnose and treat congenital heart defects. Pediatric interventional cardiology is used for treating heart conditions with minimally invasive surgical procedures.
Sizing and Forecast
The pediatric interventional cardiology market size has grown strongly in recent years. It will grow from $2.31 billion in 2023 to $2.51 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased mycotoxin awareness, stringent regulatory standards, focus on animal health, globalization of poultry production, market competitiveness, increased farm productivity.
The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing poultry industry, climate change impacts, demand for organic products, global trade dynamics, government initiatives, increasing health consciousness. Major trends in the forecast period include integration of technology, feed quality and safety, market consolidation, collaborative research efforts, digitalization in agriculture, advancements in feed technology.
To access more details regarding this report, visit the link:
Segmentation & Regional Insights
The pediatric interventional cardiology market covered in this report is segmented –
1) By Device Type: Closure Devices, Trans catheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Other Device Types
2) By Procedure: Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Other Procedures
3) By End-Use: Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions
North America was the largest region in the pediatric interventional cardiology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10384&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of congenital heart disease is expected to propel the growth of the pediatric interventional cardiology market. Congenital heart disease is any problem that has affected the heart and its structure since birth. Pediatric interventional cardiology procedures are used to treat congenital heart disease that advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of infection, and less scarring. For instance, in 2022, according to the American Heart Association, a US-based non-profit organization that is focused on cardiovascular medical research, approximately 40,000 infants in the United States are affected by congenital heart defects, and the birth prevalence of congenital heart diseases is estimated to be 12.3 per 1000 in the country. Furthermore, The Lancet, a weekly peer-reviewed general medical journal based in the United Kingdom, published an article in 2022 stating that congenital heart disease is the most common birth defect, affecting nearly 9 out of every 1000 live births. Therefore, the increasing prevalence of congenital heart disease will drive the growth of the pediatric interventional cardiology market.
Key Industry Players
Major companies operating in the pediatric interventional cardiology market report are Medtronic plc, GE HealthCare Technologies Inc., Abbott Laboratories, Cardinal Health Inc., Terumo Corporation, W.L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Siemens Healthineers, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Canon Medical Systems Corporation, Gore & Associates Inc., Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co.Ltd., Biosensors International Group Ltd., Cardiac Science Corporation, Asahi Intecc Co.Ltd., Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH
The pediatric interventional cardiology market report table of contents includes:
1. Executive Summary
- Market Characteristics
- Market Trends And Strategies
- Impact Of COVID-19
- Market Size And Growth
- Segmentation
- Regional And Country Analysis
……..
- Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
